Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection
Authors: Victoria T. Chu, Noah G. Schwartz, Marisa A. P. Donnelly, Meagan R. Chuey, Raymond Soto, Anna R. Yousaf, Emily N. Schmitt-Matzen, Sadia Sleweon, Jasmine Ruffin, Natalie Thornburg, Jennifer L. Harcourt, Azaibi Tamin, Gimin Kim, Jennifer M. Folster, Laura J. Hughes, Suxiang Tong, Ginger Stringer, Bernadette A. Albanese, Sarah E. Totten, Meghan M. Hudziec, Shannon R. Matzinger, Elizabeth A. Dietrich, Sarah W. Sheldon, Sarah Stous, Eric C. McDonald, Brett Austin, Mark E. Beatty, J. Erin Staples, Marie E. Killerby, Christopher H. Hsu, Jacqueline E. Tate, Hannah L. Kirking, Almea Matanock, Winston E. Abara, Lorraine N. Alexander, Melissa M. Arons, Melanie J. Firestone, Monique A. Foster, Elizabeth Garza, Yessica Gomez, Sarah Anne J. Guagliardo, Dana L. Haberling, Ben W. Humrighouse, Stacey L. Konkle, Perrine Marcenac, Benjamin P. Monroe, Apophia Namageyo-Funa, Michelle O’Hegarty, Caroline Q. Pratt, Ian W. Pray, Byron F. Robinson, Horacio Ruiseñor-Escudero, Hannah E. Segaloff, Talya Shragai, Tarah S. Somers, Farrell A. Tobolowsky, Rachael L. Ticho Zacks, Raydel D. Anderson, Ayan K. Chakrabarti, Blake Cherney, Stephen P. LaVoie, Kaitlin F. Mitchell, Clint N. Morgan, Rebecca Rossetti, Robyn A. Stoddard, Jeni Vuong, Melissa J. Whaley, Joaudimir Castro Georgi, Rebecca J Chancey, Erica Figueroa, Jennifer Lehman, Kristine Lindell, Reed Magleby, Grace E. Marx, David W. McCormick, Paul Mead, Laird J. Ruth, Maggie Silver, Susanna N. Visser, Michelle A. Waltenburg, Karen L Boroughs, Aaron C. Brault, Anna Drexler, Janet McAllister, Jamie Pawloski, Janae Stovall, Maria I. Dionicio Bernabe, Anna Liza M. Manlutac, Graciela Zuniga-Groot, Seema Jain, Heather Baily, Alexis Burakoff, Christopher Grano, Lindsey Martin Webb, Evelyn Alvarez, Cassandra N Bundalian, Hannah Collins, Christopher Delmonico, Shaun Dunyak, Hannah M Fortune, Wyatt Giddmore, Kimberly Huynh-Templeman, Tia Ling, Hunter Olsen, Nicholas J Pysnack, Aleigha M Ricci, Tara M. Stitzlein, Jan Drobeniuc, Sabrina Weis-Torres, Lili Punkova, Tao Lily Jia, Peter Browning, Shanna Bolcen, Panagiotis Maniatis, So Hee Park, Kimberly M. Moss, Briana Zellner, Kristina Ortiz, Anna Uehara, Adam C. Retchless, Ying Tao, Yan Li, Anna Kelleher, Han Jia Justin NG, Jing Zhang, Brian Lynch, Peter W. Cook, Clinton R. Paden, Krista Queen, Magdalena Medrzycki, Shannon Rogers, Phili Wong, Shilpi Jain, Alexandra Tejada-Strop, John Michael Metz, Ebenezer David, Xiaoling Tang, Nhien T. Wynn, Rebekah Tiller, Senthilkumar K. Sakthivel, Srinivasan Velusamy, Brett Whitaker, Marla E. Petway
Journal: JAMA Internal Medicine (2022)

Importance As self-collected home antigen tests become widely available, a better understanding of their performance during the course of SARS-CoV-2 infection is needed. Objective To evaluate the diagnostic performance of home antigen tests compared with reverse transcription–polymerase chain reaction (RT-PCR) and viral culture by days from illness onset, as well as user acceptability. Design, Setting, and Participants This prospective cohort study was conducted from January to May 2021 in San Diego County, California, and metropolitan Denver, Colorado. The convenience sample included adults and children with RT-PCR–confirmed infection who used self-collected home antigen tests for 15 days and underwent at least 1 nasopharyngeal swab for RT-PCR, viral culture, and sequencing. Exposures SARS-CoV-2 infection. Main Outcomes and Measures The primary outcome was the daily sensitivity of home antigen tests to detect RT-PCR–confirmed cases. Secondary outcomes included the daily percentage of antigen test, RT-PCR, and viral culture results that were positive, and antigen test sensitivity compared with same-day RT-PCR and cultures. Antigen test use errors and acceptability were assessed for a subset of participants. Results This study enrolled 225 persons with RT-PCR–confirmed infection (median [range] age, 29 [1-83] years; 117 female participants [52%]; 10 [4%] Asian, 6 [3%] Black or African American, 50 [22%] Hispanic or Latino, 3 [1%] Native Hawaiian or Other Pacific Islander, 145 [64%] White, and 11 [5%] multiracial individuals) who completed 3044 antigen tests and 642 nasopharyngeal swabs. Antigen test sensitivity was 50% (95% CI, 45%-55%) during the infectious period, 64% (95% CI, 56%-70%) compared with same-day RT-PCR, and 84% (95% CI, 75%-90%) compared with same-day cultures. Antigen test sensitivity peaked 4 days after illness onset at 77% (95% CI, 69%-83%). Antigen test sensitivity improved with a second antigen test 1 to 2 days later, particularly early in the infection. Six days after illness onset, antigen test result positivity was 61% (95% CI, 53%-68%). Almost all (216 [96%]) surveyed individuals reported that they would be more likely to get tested for SARS-CoV-2 infection if home antigen tests were available over the counter. Conclusions and Relevance The results of this cohort study of home antigen tests suggest that sensitivity for SARS-CoV-2 was moderate compared with RT-PCR and high compared with viral culture. The results also suggest that symptomatic individuals with an initial negative home antigen test result for SARS-CoV-2 infection should test again 1 to 2 days later because test sensitivity peaked several days after illness onset and improved with repeated testing.